143 related articles for article (PubMed ID: 10049271)
1. Treatment of murine fusariosis with SCH 56592.
Lozano-Chiu M; Arikan S; Paetznick VL; Anaissie EJ; Loebenberg D; Rex JH
Antimicrob Agents Chemother; 1999 Mar; 43(3):589-91. PubMed ID: 10049271
[TBL] [Abstract][Full Text] [Related]
2. Combined therapy in treatment of murine infection by Fusarium solani.
Ruíz-Cendoya M; Mariné M; Guarro J
J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
Wiederhold NP; Najvar LK; Bocanegra R; Graybill JR; Patterson TF
Antimicrob Agents Chemother; 2010 Mar; 54(3):1055-9. PubMed ID: 20065054
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
Ruíz-Cendoya M; Madrid H; Pastor J; Guarro J
Int J Antimicrob Agents; 2010 Feb; 35(2):152-5. PubMed ID: 20005680
[TBL] [Abstract][Full Text] [Related]
5. Treatment of murine Fusarium verticillioides infection with liposomal amphotericin B plus terbinafine.
Ruíz-Cendoya M; Pastor FJ; Capilla J; Guarro J
Int J Antimicrob Agents; 2011 Jan; 37(1):58-61. PubMed ID: 20947310
[TBL] [Abstract][Full Text] [Related]
6. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
Rodríguez MM; Pastor FJ; Serena C; Guarro J
J Antimicrob Chemother; 2009 Feb; 63(2):361-4. PubMed ID: 19054804
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antifungal treatments for murine fusariosis.
Spellberg B; Schwartz J; Fu Y; Avanesian V; Adler-Moore J; Edwards JE; Ibrahim AS
J Antimicrob Chemother; 2006 Nov; 58(5):973-9. PubMed ID: 16973654
[TBL] [Abstract][Full Text] [Related]
8. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Ho DY; Lee JD; Rosso F; Montoya JG
Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.
Anaissie EJ; Hachem R; Karyotakis NC; Gokaslan A; Dignani MC; Stephens LC; Tin-U CK
Antimicrob Agents Chemother; 1994 Nov; 38(11):2541-4. PubMed ID: 7872744
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
Connolly P; Wheat J; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
Antimicrob Agents Chemother; 1999 Feb; 43(2):322-8. PubMed ID: 9925526
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis.
Ortoneda M; Capilla J; Pastor FJ; Pujol I; Guarro J
Antimicrob Agents Chemother; 2002 Jul; 46(7):2273-5. PubMed ID: 12069988
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
Capilla J; Serena C; Pastor FJ; Ortoneda M; Guarro J
Antimicrob Agents Chemother; 2003 Dec; 47(12):3976-8. PubMed ID: 14638514
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592).
Tu EY; McCartney DL; Beatty RF; Springer KL; Levy J; Edward D
Am J Ophthalmol; 2007 Feb; 143(2):222-227. PubMed ID: 17258521
[TBL] [Abstract][Full Text] [Related]
14. Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
Vagace JM; Sanz-Rodriguez C; Casado MS; Alonso N; Garcia-Dominguez M; de la Llana FG; Zarallo L; Fajardo M; Bajo R
BMC Infect Dis; 2007 May; 7():40. PubMed ID: 17493279
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
Serena C; Gilgado F; Mariné M; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2006 Jun; 50(6):2240-3. PubMed ID: 16723595
[TBL] [Abstract][Full Text] [Related]
16. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.
Raad II; Hachem RY; Herbrecht R; Graybill JR; Hare R; Corcoran G; Kontoyiannis DP
Clin Infect Dis; 2006 May; 42(10):1398-403. PubMed ID: 16619151
[TBL] [Abstract][Full Text] [Related]
17. Effect of voriconazole on a corneal abscess caused by fusarium.
Polizzi A; Siniscalchi C; Mastromarino A; Saccà SC
Acta Ophthalmol Scand; 2004 Dec; 82(6):762-4. PubMed ID: 15606478
[TBL] [Abstract][Full Text] [Related]
18. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
Consigny S; Dhedin N; Datry A; Choquet S; Leblond V; Chosidow O
Clin Infect Dis; 2003 Jul; 37(2):311-3. PubMed ID: 12856225
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of voriconazole in a murine model of invasive paecilomycosis.
Rodríguez MM; Pastor FJ; Serena C; Guarro J
Int J Antimicrob Agents; 2010 Apr; 35(4):362-5. PubMed ID: 20129763
[TBL] [Abstract][Full Text] [Related]
20. Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.
Graybill JR; Najvar LK; Johnson E; Bocanegra R; Loebenberg D
Antimicrob Agents Chemother; 2004 Jun; 48(6):2288-91. PubMed ID: 15155236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
